The Americas GERD & NERD treatment market is expected to grow USD 4.99 at the CAGR of 6.20% during the forecast period 2023-2030.

Acid reflux has been a common problem in lifestyle of the average US citizen. The Americas GERD and NERD treatment market is expecting a solid development amid the estimated period. GERD is one of the generally watched gastrointestinal disease over the globe. The pervasiveness of acid reflux and related manifestations has expanded worldwide by about half of the recent decade. Nonetheless, the disease has effects on the wellbeing and nature of patient lives. The significant driving components for the development of the market expanding instances of smoking, changing way of life and unpredictable dietary propensities, expanding rate of indigestion issue (acid reflux). In any case, loss of patent restrictiveness and absence of pipeline medications may moderate the development of the market amid the determined period. The U.S. Census Bureau stated that at least 35% to 40% of the geriatric patients to have at least 1 gastrointestinal symptom in a year. Geriatric population is more prone to develop gastric diseases due to poor immunity and imbalances in the hemostasis of the body. 

As indicated by National Institutes of Health (NIH), it is assessed that 20% of the U.S. population is influenced by GERD and is in charge of 9 million in the U.S. outpatient visit every year. Stomach settling agents are most regularly used to treat GERD and NERD, however there has been watched change in pattern and proton pump inhibitor drugs are utilized to treat GERD and NERD even are accessible in finished the counter. New innovation reports that GERD might be dealt with by stretta methodology in brief time. Stretta treatment is an insignificantly obtrusive system, which helps in lessening GERD indications, enabling the dominant part of patients to wipe out or to a great extent diminish the utilization of PPIs (proton pump inhibitors).

The Americas GERD & NERD treatment market is expecting a healthy growth during the forecasted period. ERD is one of the commonly observed gastrointestinal disorders across the globe. The prevalence of acid reflux and related symptoms has increased worldwide by nearly 50% over the last decade. However, disorder has major effects on the health and quality of patient lives. The major driving factors for the growth of the market increasing cases of smoking, changing lifestyle and irregular dietary habits, increasing incidence of acid reflux disorder (heartburn). However, loss of patent exclusivity and lack of pipeline drugs may slow the growth of the market during the forecasted period.

Major players in GERD & NERD treatment market

Some of the major players in this market are AstraZeneca Plc (U.K), Boston Scientific Corporation (U.S.), Cempra Inc. (U.S.), Eisai Co., Ltd. (Japan), EndoGastric Solutions Inc. (U.S.), EndoStim Inc. (U.S.), GlaxoSmithKline Plc (U.K), Ironwood Pharmaceuticals, Inc. (U.S.), Jeil pharmaceutical Co. Ltd. (South Korea), Johnson & Johnson (U.S.), Mederi Therapeutics Inc. (U.S.), Medigus Ltd. (Israel), Medtronic Inc. (U.S.), Merck & CO., Inc. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Teva Pharmaceuticals Industries Limited (Israel), Torax Medical (U.S.), Valeant Pharmaceuticals International, Inc. (Canada), Carbon Medical technologies (U.S.), Allegiant health (U.S.), Tya pharmaceuticals (U.S.), Sanofi (France).

Segmentation:

Americas GERD & NERD treatment market Insights is segmented on the basis of drug class, dosage form, and end user. On the basis of drug class, the market is segmented into antacids (acid neutralizers), proton pump inhibitors, H2 receptor blocker, prokinetic agents, antidepressants, calcium channel blockers, and others. Proton pump inhibitors are further segmented into esomeprazole, omeprazole, pantoprazole, lansoprazole, dexlansoprazole, rabeprazole, and others. H2 receptor blocker is further segmented into ranitidine, famotidine, cimetidine, nizatidine, and others. Prokinetic agents are further segmented into domperidone, metoclopramide, itopride, prucalopride, cisapride, benzamide, mosapride, erythromycin, and others. Based on the dosage form, it is segmented into solid and liquid. On the basis of the end user, it is segmented into hospitals & clinics, research centers, and others.

Regional Analysis

Considering the Americas GERD & NERD treatment market, there are two main regions: North America, and South America. North America consists of U.S. and Canada. The U.S. holds the largest market share due to the increasing burden of diseases, the share for gastric diseases is also increasing. The prevalence of acid reflux and related symptoms are increased across the globe by nearly 50% over the last decade.

Moreover, among all the geographical regions, North America has the highest GERD (gastroesophageal reflux disease) prevalence of 18.1%-27.8%. In North America, the U.S. has the highest prevalence of 26.2%.

According to the University of Michigan, more than 60 million American adults suffer from heartburn at least once a month and over 25 million experience heartburn daily. About 42% of the U.S. population experience heartburn at some point.

The American Cancer Society estimated that about 28,000 cases of stomach cancer are expected to diagnose and nearly 10,960 people may die from stomach cancer in 2017

According to the American Cancer Society, there were nearly 24,590 new cases of stomach cancer in 2015 and 10,720 deaths in the same year.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions